← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Invenio Therapeutics, Inc.
Cleveland, OH
$2,039,426
Total funding
4
Grants
Funding over time
peak $775.8K · FY2008–15$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$2,039,426 · 4
By mechanism
R44$1,763,248 · 2
R43$276,178 · 2
Investigators at Invenio Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Original Phase 1 Title: Identifying Small Molecule Inhibitors of HdmX using Cell-based Screening Revised Title: Development of a Novel HdmX Inhibitor for Leukemia$775,796
R44 · FY2015 · CA
Natural product-derived differentiation agents for AML$434,480
R44 · FY2011 · CA
Natural product-derived differentiation agents for AML$410,512
R44 · FY2012 · CA
Plant-derived differentiation agents for AML$142,460
R43 · FY2008 · CA
Natural product-derived differentiation agents for AML$142,460
R44 · FY2014 · CA
Novel differentiation therapy for AML$128,230
R43 · FY2008 · CA
Novel differentiation therapy for AML$5,488
R43 · FY2009 · CA